Key Takeaways
- • ICG Enterprise Trust (ICGT) posted a 3.3% total investment return, or NAV total return, for the six months to 31 July 2026, on a £1.3bn private equity portfolio.
- • Direct investments returned 6.8% and primary fund investments grew 2.6%, offsetting a 3.2% decline in secondary stakes.
- • Portfolio companies grew revenue 11% and operating profit 16% over 12 months, with the top 30 holdings representing 37% of assets.
- • The trust made £84m of disposals and expects a further £70m from the exit of its largest holding, Exail (3.4%), in the second half.
- • ICGT returned £20m through buybacks and declared a second quarterly dividend of 9.5p, keeping it on track for a 42p full-year target, up 8% year on year.
Summary
ICG Enterprise Trust (ICGT) reported a "resilient" first-half performance, posting a 3.3% total investment return in the six months to 31 July 2026. The £1.3bn private equity portfolio's growth was driven by "multiple investment areas," according to the company's interim results, at a time when markets are focused on the rapid rollout of artificial intelligence and concerned about rising inflation and government debt. Per the trust's disclosures, the NAV per share total return was 3.3% for the period, with a five-year annualised return of 8.4%.
By investment type, direct investments, where ICGT co-invests in private companies alongside a fund manager, returned 6.8%. Primary investments in private equity funds bought at launch grew 2.6%. These gains were partly offset by a 3.2% decline in secondary stakes, which are fund interests bought from other investors. Portfolio companies continued to grow, with revenue up 11% and operating profit up 16% over the past 12 months. The global portfolio is diversified, with its top 30 holdings accounting for 37% of assets. The trust's three best-performing holdings in the half were all US companies: Brooks Automation, a semiconductor support services provider; pest controller Greenix; and New York-based accountants CohnReznick.
Portfolio manager Oliver Gardey continued to recycle capital during the period, completing £84m of disposals. The largest was the £23m exit from Boston-based Curium Pharma. A further £70m of proceeds may be received in the second half from the exit of Exail, a French provider of autonomous systems for the aerospace and maritime sectors and the trust's largest holding at 3.4%. On new commitments, the trust made £65m of new investments and £104m of new fund commitments, including to its in-house manager Intermediate Capital Group (ICG) and external managers Gridiron, TJC and Archimed.
On shareholder returns, the trust, which yields around 3%, bought back £20m of shares and declared a second quarterly dividend of 9.5p per share. This forms part of a 42p target for the financial year, an 8% increase on the prior year.
By investment type, direct investments, where ICGT co-invests in private companies alongside a fund manager, returned 6.8%. Primary investments in private equity funds bought at launch grew 2.6%. These gains were partly offset by a 3.2% decline in secondary stakes, which are fund interests bought from other investors. Portfolio companies continued to grow, with revenue up 11% and operating profit up 16% over the past 12 months. The global portfolio is diversified, with its top 30 holdings accounting for 37% of assets. The trust's three best-performing holdings in the half were all US companies: Brooks Automation, a semiconductor support services provider; pest controller Greenix; and New York-based accountants CohnReznick.
Portfolio manager Oliver Gardey continued to recycle capital during the period, completing £84m of disposals. The largest was the £23m exit from Boston-based Curium Pharma. A further £70m of proceeds may be received in the second half from the exit of Exail, a French provider of autonomous systems for the aerospace and maritime sectors and the trust's largest holding at 3.4%. On new commitments, the trust made £65m of new investments and £104m of new fund commitments, including to its in-house manager Intermediate Capital Group (ICG) and external managers Gridiron, TJC and Archimed.
On shareholder returns, the trust, which yields around 3%, bought back £20m of shares and declared a second quarterly dividend of 9.5p per share. This forms part of a 42p target for the financial year, an 8% increase on the prior year.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.